CATX · Perspective Therapeutics, Inc. · Executive Compensation
$1.19
-0.02 (-1.65%)
At close · Oct 27
Return incl. dividend (before tax)
Q4 2022 earnings call transcript
Market Cap
$135.84M
Shares
114.15M
Volume · Oct 27
8.74M
Avg daily vol (3M)
1.92M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Lori A. Woods | Former CEO | $768,694 |
| Jennifer Streeter | Former COO and VP of HR | $555,695 |
| William Cavanagh III | Former CRDO | $514,680 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Lori A. Woods | Former CEO | $371,195 |
| Jennifer Streeter | Former COO and VP of HR | $266,349 |
| William Cavanagh III | Former CRDO | $253,339 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Joel Sendek | Chief Financial Officer | Appointed | 2025-09-04 |
| Maya Martinez-Davis | member of the Board | Appointed | 2025-09-03 |
| Juan Graham | Chief Financial Officer and principal financial officer | Appointed | 2025-01-06 |
| Mark Austin | co-principal financial officer and principal accounting officer | Terminated | 2024-08-30 |
| Robert Froman Williamson, III | Director | Appointed | 2024-05-31 |
| Frank Morich, M.D., Ph.D. | Director | Appointed | 2024-05-31 |
| Johan (Thijs) Spoor | Director | Appointed | 2024-05-31 |
| Heidi Henson | Director | Appointed | 2024-05-31 |
| Lori A. Woods | Director | Appointed | 2024-05-31 |
| Robert Froman Williamson, III | Board | Appointed | 2023-10-12 |
| Johan (Thijs) Spoor | Board | Appointed | 2023-10-12 |
| Heidi Henson | Board | Appointed | 2023-10-12 |
| Frank Morich, M.D., Ph.D. | Board | Appointed | 2023-10-12 |
| Lori A. Woods | Board | Appointed | 2023-10-12 |
| Jennifer Streeter | Chief Operating Officer and Vice President of Human Resources | Terminated | 2023-07-14 |
| Lori Woods | Chair of the Compensation Committee | Resigned | 2023-05-15 |
| Rob Williamson, III | Chair of the Audit Committee | Resigned | 2023-05-15 |
| Heidi Henson | director | Appointed | 2023-05-15 |
| Michael McCormick | Board of Directors | Resigned | 2023-05-15 |
| William Cavanagh III | Chief Research and Development Officer | Terminated | 2023-02-10 |
| Lori Woods | CEO | Resigned | 2023-02-06 |
| Robert Froman Williamson, III | director of the Company | Appointed | 2023-02-06 |
| Dr. Frank Morich | director of the Company | Appointed | 2023-02-06 |
| Lori A. Woods | Chairperson of the Board | Appointed | 2023-02-06 |
| Johan (Thijs) Spoor | Chief Executive Officer | Appointed | 2023-02-06 |
Leadership
- Johan (Thijs) Spoor CEO, Board Member
- Thijs Spoor CEO
- Lori A. Woods Chairman, Board Member
- Joel Sendek CFO
- Jonathan Hunt Chief Accounting Officer
- Alan Hoffmann Board Member
- Dr. Frank Morich Board Member
- Frank Morich Board Member
- Frank Morich, M.D., Ph.D. Board Member
- Heidi Henson Board Member
- Maya Martinez-Davis Board Member
- Michael W. McCormick Board Member
- Philip J. Vitale, M.D. Board Member
- Robert Froman Williamson Board Member
- Robert Froman Williamson, III Board Member
Key facts
CIK
728387
CUSIP
46489V302
13F (30d)
14 filings
14 filers
Visit website
Investor relations